Clifford A. Bernstein, MD's portrait
Clifford A. Bernstein, MD
Newport Beach Headache and Pain Institute
Newport Beach, CA

About Clifford A. Bernstein, MD

Board certified by the American Board of Anesthesiology, American Board of Pain Medicine and American Society of Addiction Medicine, Dr. Bernstein possesses an in-depth knowledge and thorough understanding of pain management and opiate dependence. Dr. Bernstein is nationally recognized for his pioneering work in the field of addiction medicine and neurostimulation. Dr. Bernstein is currently involved extensively in several research projects in these areas.

He is currently an Assistant Clinical Professor of Anesthesia at the University of California, Irvine. He earned his medical degree from Rutgers University School of Medicine. His post-doctorate training was at Thomas Jefferson University Hospital in Philadelphia.

Dr. Bernstein is a member of the International Spine Intervention Society, American Association of Interventional Pain Practioners, and the International Association for the Study of Pain, among many other professional societies. He served on the Board of Directors at Tustin Hospital and Medical Center and is the Quality Director at Newport Coast Medical Center.

Dr. Bernstein currently operates a very busy chronic pain management practice in Newport Beach, CA. Dr. Bernstein stresses the judicious use of opiate medications and frequently utilizing neuromodulating devices to ease his patient's pain. Dr. Bernstein is a pioneer in the fields of anesthesia-assisted opiate detoxification and spinal cord stimulation.

Publications

Publications

1. Paicius R, Bernstein C, Lempert-Cohen C. Peripheral Nerve Field Stimulation in Chronic Abdominal Pain: A Case Report of Three Novel Applications, Pain Physician, July 2006.

Research

1. Carbon Fiber Ligament Knee Prosthesis. Summer 1985.

2. Joseph J, Torjman M, Bernstein CA: Intraoperative monitoring of dynamic lung compliance during thoracotomy procedures. Abstract published Anesthesiology, 1993.

3. Bernstein CA, Torjman M, Ritter D: Preoperative glycopyrrolate: PO, IM or IV administration? Abstract published Anesthesia & Analgesia. 1993. Paper published Journal of Clinical Anesthesia, 1996.

4. McNulty S, Odorisio L, Bernstein CA: Serotonin variability during CPB: The effect of sampling site and time. Abstract published Anesthesia & Analgesia, 1993.

5. Heropoulos M, Bernstein CA: Sevoflurane Study: A phase HI, multi-center, open label, randomized, comparative study evaluating the use of Sevoflurane versus isoflurane in the maintenance of anesthesia in elderly, ASA Class I, II and III inpatient.

6. Bernstein CA, Ghouri A: Propofol Narcotic Mixtures: assessment of homogenicity. Abstract published Anesthesia and Analgesia, 1996.

7. Bernstein CA, Waters JH: Hetastarch versus Albumin: Comparative effects on coagulation via thromboelastography. Abstract published Anesthesia and Analgesia, 1996.

8. Waters JH, Bernstein CA: Acid-Base Change Following Hetastarch or Albumin. Abstract published Anesthesia and Analgesia, 1996.

9. Waters, JH, Miller L., Bernstein CA: Causes of Metabolic Acidosis in Prolonged Surgery. Abstract published IARS, 1995.

Presentations

1. Preoperative Glycopyrrolate: PO, IM or IV administration. Poster Presentation Feb., IARS 1992.

2. Glycopyrrolate, Possible silent aspiration prophylaxis. Medical Monitoring Technology Conference. Vail, CO, February 1992.

3. Anesthesia for Transplantation Surgery. UCI Lecture Series.

4. The Anesthesia Machine and Ventilator. UCI Lecture Series.

5. Examination and Diagnosis of the Patient with Chronic Low Back Pain, UCI Lecture Series

6. Anesthesia for Adrenal Cortex Dysfunction and Pheochromocytoma. UCI Lecture Series.

7. New Devices for Management of the Difficult Airway. Hoag Hospital, Newport Beach, CA, Jan. 1995, UCI Emergency Department, August 1995, Kaiser Hospital, August 1995.

8. Examination and Diagnosis of the Patient with Chronic Low Back Pain. FHP - Fountain Valley, CA, March 1995.

9. Accelerated Opiate Neuro-Regulation, National Association of Sentencing Advocates, Annual Conference, June 2000.

10. Accelerated Opiate Neuro-Regulation a Medical Supplement, National Association of Addition Treatment Providers, Annual Conference, May 2001.

11. Rapid Detoxification and Opioid Hyperalgesia, University of California - Irvine, Alumni Pain Symposium, 10/8/04.

12. Spinal Cord Stimulation and Opioid Induced Hyperalgesia, Idaho Pain Society, Key Note Speaker, 10/15/05.

13. A Clinical Evaluation of the Genesis Implantable Pulse Generator (IPG) in combination with ANS leads for the management of Chronic pain of the trunk and limbs. Lead Investigator. Anticipated publication June 2006 Journal of Neuromodulation.

14. Advanced Topics in Neuromodulation, 3/10/06 - 3/11/06 San Diego, CA Moderator.

Articles Written by Clifford A. Bernstein, MD

Spinal Cord Stimulation for the Control of Chronic Back Pain

Spinal cord stimulation, also called neurostimulation, may allow patients to achieve significant or total relief from chronic back pain.

Spinal Cord Stimulation: Advantages and Risks and Who is a Candidate?

Are you a candidate for spinal cord stimulation? Review the advantages and risks to this pain management technique used for chronic pain patients. Article reviews who can have spinal cord stimulation.

Financial Disclosures

SpineUniverse, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy. 

To help achieve this goal, SpineUniverse requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

This author has not yet submitted a Financial and Other Disclosures form.
SHOW MAIN MENU
SHOW SUB MENU
Cancel
Delete